Finance

Lists
Why is 9606 up 10,89%?
Dive Deeper
9606:HKG
Duality Biotherapeutics Inc
170,00 HK$
+10,89%
(+16,70) 1D
16 қаз., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9606...
Open
154,50 HK$
High
179,60 HK$
Low
154,50 HK$
Mkt. cap
13,57 млрд
Avg. vol.
770,17 м.
Volume
1,74 млн
52-wk high
376,80 HK$
52-wk low
151,40 HK$
EPS
-18,69 HK$
No. of employees
266
Open
154,50 HK$
High
179,60 HK$
Low
154,50 HK$
Mkt. cap
13,57 млрд
Avg. vol.
770,17 м.
Volume
1,74 млн
52-wk high
376,80 HK$
52-wk low
151,40 HK$
EPS
-18,69 HK$
No. of employees
266
News stories
From web sources and news partners
About Duality Biotherapeutics Inc
CEO-
Employees266
Founded2019 ж. 03 шіл.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
311,40 млн
311,40 млн
109,66 млн
109,66 млн
Cost of goods sold
311,55 млн
311,55 млн
226,34 млн
226,34 млн
Cost of revenue
311,55 млн
311,55 млн
226,34 млн
226,34 млн
Research and development expenses
244,19 млн
244,19 млн
303,33 млн
303,33 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44,53 млн
44,53 млн
40,77 млн
40,77 млн
Operating expense
288,00 млн
288,00 млн
342,03 млн
342,03 млн
Total operating expenses
599,55 млн
599,55 млн
568,37 млн
568,37 млн
Operating income
-288,15 млн
-288,15 млн
-458,70 млн
-458,70 млн
Other non operating income
6,86 млн
6,86 млн
-
-
EBT including unusual items
-260,48 млн
-260,48 млн
-458,77 млн
-458,77 млн
EBT excluding unusual items
-264,12 млн
-264,12 млн
-459,70 млн
-459,70 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-722,50 м.
-722,50 м.
-2,08 млн
-2,08 млн
Net income
-260,48 млн
-260,48 млн
-458,77 млн
-458,77 млн
Net profit margin
-83,65%
-83,65%
-418,34%
-418,34%
Earnings per share
-
-
-
-
Interest and investment income
29,92 млн
29,92 млн
25,95 млн
25,95 млн
Interest expense
-318,50 м.
-318,50 м.
-1,27 млн
-1,27 млн
Net interest expenses
29,60 млн
29,60 млн
24,68 млн
24,68 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-286,03 млн
-286,03 млн
-456,26 млн
-456,26 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары